Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.
Enfusion, Inc. (symbol: ENFN) is a pioneering provider of cloud-based portfolio management and risk systems, headquartered in Chicago, Illinois. With branch offices in New York, as well as wholly-owned subsidiaries in London and Hong Kong, Enfusion stands at the forefront of delivering innovative solutions to clients within the financial services industry. Their advanced software as a service (SaaS) platform empowers investment managers by unifying mission-critical systems and providing a single dataset for real-time performance, risk calculations, and accounting of complex financial products.
Enfusion's core business revolves around transforming the investment management industry by eliminating technology and information barriers, allowing investment managers to make informed decisions swiftly and efficiently. The company's solutions simplify investment and operational workflows, coalescing data into a single source of truth. This integrated approach helps clients manage over $90 billion in assets across some of the world's largest and most respected hedge funds.
Enfusion's recent achievements highlight its exceptional growth trajectory. The company has expanded its operations significantly, with maximum revenue generation from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa. Their innovative platform is trusted by numerous global clients for its real-time performance and robust risk management capabilities.
Enfusion continues to innovate and refine its offerings. Some of their current projects include enhancing their cloud-based solutions to further streamline investment processes and improve data accuracy. The company also emphasizes strong partnerships and collaboration with other industry leaders to bring the latest technological advancements to their clients.
Financially, Enfusion is on solid footing, experiencing rapid growth and affirming its position as a leader in the investment management software industry. The company's client base spans across the globe, relying on Enfusion's cutting-edge solutions to navigate the complexities of financial management.
Overall, Enfusion, Inc. is a crucial player in the financial services industry, known for its commitment to innovation, client satisfaction, and delivering value through state-of-the-art technology.
Enfusion reported strong fourth-quarter revenue growth of 41% year-over-year, totaling $31.9 million. The company's Platform Subscriptions revenue rose 39% to $28.9 million, driven by new client additions and existing client growth. Despite the revenue increase, Enfusion posted a net loss of $293.9 million for the quarter, compared to a net income of $12.2 million a year earlier. For 2022, Enfusion anticipates total revenue between $147 million and $150 million, with a projected Adjusted EBITDA of $32.8 million to $33.8 million.
FTV Capital has successfully closed FTV VII, its largest fund to date, with commitments of
Enfusion, a leader in cloud-native investment management software, will release its fourth quarter fiscal year 2021 financial results post-market on March 24, 2022. A conference call will follow at 2:00 PM PT / 5:00 PM ET to discuss results and offer financial guidance. Investors can access the call by dialing (844) 200-6205 domestically or (929) 526-1599 internationally, using conference ID 738165. Enfusion serves over 650 investment managers globally, facilitating real-time data-driven intelligence across all office teams.
Enfusion, Inc. (NYSE: ENFN) announces the retirement of founder Tarek Hammoud from its Board of Directors. Hammoud, who founded the company over 25 years ago, expressed pride in the firm's achievements and confidence in its leadership team for future growth. CEO Thomas Kim praised Hammoud's contributions and emphasized the importance of continuing the company's strategic initiatives. Enfusion provides cloud-native investment management software services, partnering with over 650 investment managers globally.
Enfusion, Inc. (NYSE: ENFN) has announced the promotion of Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of Sales for EMEA. These promotions underscore Enfusion’s commitment to global expansion and internal talent development. Iris, based in New York, will drive strategic initiatives and has a robust background in strategy, including tenure at Bridgewater Associates and Boston Consulting Group. Lotte will focus on business development across Europe, the Middle East, and Africa, building on her successful track record since joining Enfusion in 2020.
Enfusion, Inc. has partnered with Coinbase Global Inc. to integrate systems for seamless cryptocurrency trading, marking Coinbase's first collaboration with an OEMS provider. This connection will enable financial institutions to view and trade crypto alongside traditional assets using Enfusion's platform. Expected to be completed in Q2 2022, this integration aims to meet rising institutional demand for crypto exposure. Enfusion supports diverse asset classes and has established itself as a leader in investment management software.
Enfusion, Inc. (NYSE: ENFN) has launched significant updates to its mobile app, enhancing its front-to-back-office investment management platform. The app now offers real-time access to portfolio management, compliance monitoring, and secure document sharing for portfolio managers and traders. With over 680 investment managers utilizing their cloud-based services, the app's functionalities include robust order and execution management, enabling seamless trading regardless of physical location. This innovation aligns with industry trends towards increased decentralization and flexibility in asset management.
Enfusion, a cloud-based investment management software provider, has announced the opening of its first office in Sydney, Australia. This expansion aims to meet the growing demand for operational solutions from investment managers in Australia and New Zealand. CEO Thomas Kim highlighted the company's commitment to enhancing service for existing clients and expanding their global presence, having already entered the Asia-Pacific market in 2019. The Sydney office marks their tenth global location, reinforcing Enfusion’s strategy to offer customized SaaS solutions worldwide.
Enfusion (NYSE: ENFN) has announced the appointment of Bronwen Bastone as Chief People Officer and the election of Jan Hauser and Kathleen DeRose to its Board of Directors. Bastone brings over 20 years of experience in human capital management, previously holding senior roles at major financial institutions. DeRose and Hauser will enhance the board's expertise in financial services and fintech. CEO Thomas Kim expressed confidence in the new appointments as Enfusion aims to strengthen its leadership and client service capabilities.
FAQ
What is the current stock price of Enfusion (ENFN)?
What is the market cap of Enfusion (ENFN)?
What does Enfusion, Inc. do?
Where is Enfusion headquartered?
What is Enfusion's core business focus?
How much in assets do Enfusion's clients manage?
In which regions does Enfusion generate the most revenue?
What recent achievements has Enfusion made?
What kind of clients does Enfusion serve?
How does Enfusion simplify investment and operational workflows?
What are some current projects Enfusion is working on?
What is Enfusion's market position?
